about
P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharideDistinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neuronsNeurotrophin secretion: current facts and future prospects.The effect of treatment with BRX-220, a co-inducer of heat shock proteins, on sensory fibers of the rat following peripheral nerve injuryCB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cordInhibition of spinal microglial cathepsin S for the reversal of neuropathic painRapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammationThe Monoiodoacetate Model of Osteoarthritis Pain in the MouseMAP kinase and pain.Brain-derived neurotrophic factor induces NMDA receptor subunit one phosphorylation via ERK and PKC in the rat spinal cord.Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.GDNF and somatostatin in sensory neurones.Environmental cold exposure increases blood flow and affects pain sensitivity in the knee joints of CFA-induced arthritic mice in a TRPA1-dependent manner.Calcitonin gene-related peptide-expressing sensory neurons and spinal microglial reactivity contribute to pain states in collagen-induced arthritisNeuron-immune mechanisms contribute to pain in early stages of arthritis.Chemokines and pain mechanisms.microRNAs in nociceptive circuits as predictors of future clinical applications.Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's diseaseCurrent challenges in glia-pain biology.Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain.Microglial signalling mechanisms: Cathepsin S and Fractalkine.Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states.Assessment and treatment of pain in people with dementia.Astrocytes--multitaskers in chronic pain.Neuropathic pain and cytokines: current perspectives.Fractalkine/CX3CR1 signaling during neuropathic pain.The role of glia in the spinal cord in neuropathic and inflammatory pain.The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain.Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain.Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells.Chronic pain: new insights in molecular and cellular mechanisms.GABAB receptors and pain.Development of monosodium acetate-induced osteoarthritis and inflammatory pain in ageing miceIntrathecally delivered glial cell line-derived neurotrophic factor produces electrically evoked release of somatostatin in the dorsal horn of the spinal cord.Intrathecally injected neurotrophins and the release of substance P from the rat isolated spinal cord.Selective activation of microglia facilitates synaptic strength.The liberation of fractalkine in the dorsal horn requires microglial cathepsin S.The role of G-protein receptor 84 in experimental neuropathic pain.Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions.Effect of brain-derived neurotrophic factor on the release of substance P from rat spinal cord.
P50
Q24600711-DCE6D0C9-5567-4C9A-B4FA-BF8B28AE3870Q24632552-D3E091F4-AC31-4AC5-B4DF-1DBAF25ED76EQ27919638-085EF9E8-AE4E-46C9-A90E-FA5E02421EF8Q28242878-51602947-9B5F-4F37-BB79-3336F13642CDQ28344830-1B42767E-BD33-4B88-A0C6-CDFBDD1955D6Q28572461-27ED443C-12DF-401A-A25F-115790CE686EQ28574292-F502AC89-1675-40A9-ABF2-C06ABF95D6C8Q28830426-7EC848D3-08C0-42AD-9F8B-584F9784942CQ30482277-284B3360-FA61-4A59-BF1F-97EB9D415C77Q34349898-7CCB52D3-C6A9-4654-8AEC-81FFC2479EB4Q34780006-D5EC44E5-4408-438E-9F36-3F936DF0A059Q35054341-82830DD6-6676-4D04-88B2-D1FB9E1FEB62Q35891181-AEAFB1EF-6530-4B8B-AEFC-A0876AC1E1B4Q36799724-45A649F9-AC8B-4738-820A-1945C7591FACQ36853784-1C0A8193-9FD6-458F-A548-0FE26B27AAE3Q37215729-090005D4-1D56-46E3-BA75-C6858B5275ACQ37233099-78D04BF8-ABDC-442B-BAB3-49F61BFAC249Q37265855-65083E00-20EE-4515-AB85-9B3D0D3F97ADQ37617623-DC507F1D-C8F5-4015-9BB5-B7B19154526EQ37726633-43381BBE-E6E1-4F01-9D9B-5641BE973231Q37938541-9CC31EB6-A550-47FE-A65C-533DEEE82FD8Q37953080-F1271AD1-D097-4CB2-B1A9-A3B5EA363C21Q38001219-C77ADE86-8572-4037-8F77-2122FCE2608BQ38092942-96506346-A08B-4345-8963-C7F1755A0AA2Q38167771-DF0ABB92-C3BB-4727-A889-3FD8FA5BC327Q38213379-A62F5D3B-9364-4590-B7DC-0F28C721C9EDQ38407843-ACAF0AFA-F2BF-49A8-8374-CEC57371577EQ39038441-216E1AB1-E641-43B7-A890-344CA1A90252Q39180678-2276B9DF-AF0F-4B53-8303-1133A0F370CBQ39271771-C571E521-9A78-4727-8791-D392451FFF1CQ39273335-23F9E3DA-7B97-4E34-A739-F7C8D0E4BC47Q39306491-23359FA3-1DF0-4AE3-A69E-278E26B10C24Q40633851-4CA8AC54-0A15-40B3-A7D8-C639A2433BFCQ40791404-08B85F52-506E-4B7A-BF60-47B589449F87Q40903406-951B5BE2-FB6C-4CB2-8EB7-F0E2C54EBFDCQ41194915-4A617D50-5BFA-49E0-A615-6EA89827171FQ41375167-F4B53BDA-784A-4FD7-92E7-0A4CDA56799EQ41972808-32BEA51A-9008-48F4-A7A0-33CFEC8437ECQ42429794-B4E212B0-DAA9-4018-8798-A110FE154125Q42499837-A7DC9994-6EAD-499B-8017-254501F221C5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marzia Malcangio
@ast
Marzia Malcangio
@en
Marzia Malcangio
@es
Marzia Malcangio
@nl
Marzia Malcangio
@sl
type
label
Marzia Malcangio
@ast
Marzia Malcangio
@en
Marzia Malcangio
@es
Marzia Malcangio
@nl
Marzia Malcangio
@sl
prefLabel
Marzia Malcangio
@ast
Marzia Malcangio
@en
Marzia Malcangio
@es
Marzia Malcangio
@nl
Marzia Malcangio
@sl
P106
P21
P31
P496
0000-0003-4296-5727